公开(公告)号：WO2008043944A3

公开(公告)日：2008-04-17

申请号：PCT/FR2007/052086

申请日：2007-10-05

Applicant: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE, DITE SILAB ,  PAUFIQUE, Jean

Inventor： PAUFIQUE, Jean

IPC: A61K8/97 ,  A61Q19/08 ,  A61P17/00 ,  A61K36/55

Abstract: L'objet de l'invention est l'utilisation d'au moins un principe actif issu de Lin capable d'agir sur le derme papillaire, pour la préparation d'une composition cosmétique et/ou dermopharmaceutique destinée à lutter contre le vieillissement cutané.

公开(公告)号：WO2008012548A1

公开(公告)日：2008-01-31

申请号：PCT/GB2007/002851

申请日：2007-07-27

Applicant: SINCLAIR PHARMACEUTICALS LIMITED ,  MASTRONDONATO, Marco

Inventor： MASTRONDONATO, Marco

IPC: A61K47/32 ,  A61K47/36 ,  A61K36/55 ,  A61P27/04

CPC classification number: A61K36/55 ,  A61K9/0048 ,  A61K31/728 ,  A61K2300/00

Abstract: The present invention relates to the application of linseed extract to the eye. Linseed extract is useful in the manufacture of a medicament of the treatment of Dry Eye, and for delivering a drug to the eye.

Abstract translation: 本发明涉及亚麻籽提取物在眼睛中的应用。 亚麻子提取物可用于制造治疗干眼症并将药物递送至眼睛的药物。

公开(公告)号：WO2007060368A1

公开(公告)日：2007-05-31

申请号：PCT/FR2006/051220

申请日：2006-11-23

Applicant: PHYSCIENCE ,  CHARAGNAC, Jean-Luc

Inventor： CHARAGNAC, Jean-Luc

IPC: A61K36/85 ,  A61K36/55 ,  A61P15/12 ,  A61K36/537

CPC classification number: A61K31/07 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4415 ,  A61K36/48 ,  A61K36/537 ,  A61K36/55 ,  A61K36/85 ,  A61K45/06 ,  A61K2300/00

Abstract: L'invention concerne une composition phytohormonale et son utilisation comme substitutif hormonal, comprenant une combinaison d'extraits de végétaux riches en lignanes et d'extrait de gattilier, et son utilisation pour le traitement des troubles de la préménopause et de la ménopause, ainsi que de l'andropause.

Abstract translation: 本发明涉及植物激素组合物及其作为激素替代物的用途，其包含富含木酚素的植物提取物和贞操树提取物的组合，以及其用于治疗绝经前，绝经期以及绝经障碍的用途。

公开(公告)号：WO2005086619A3

公开(公告)日：2006-09-14

申请号：PCT/US2004033354

申请日：2004-10-08

Applicant: MCLEAN HOSPITAL CORP ,  RENSHAW PERRY F ,  CARLEZON WILLIAM A JR ,  COHEN BRUCE M

Inventor： RENSHAW PERRY F ,  CARLEZON WILLIAM A JR ,  COHEN BRUCE M

IPC: A61K36/00 ,  A61K31/202 ,  A61K31/225 ,  A61K31/513 ,  A61K31/7072 ,  A61K36/55

CPC classification number: A61K45/06 ,  A61K31/20 ,  A61K31/202 ,  A61K31/225 ,  A61K31/513 ,  A61K31/7068 ,  A61K31/7072 ,  A61K2300/00

Abstract: The invention provides methods for treating or preventing psychiatric disorders, substance abuse disorders, and other conditions, e.g., cardiovascular disease and cancer, involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine­ containing compound, adenosine-containing, adenosine-elevating compound, omega-3 fatty acids, or combinations thereof to a mammal. The invention further provides methods of enhancing neurodevelopment and delaying premature pregnancy by administration of an effective amount of a cytosine­containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, adenosine-elevating compound, omega-3 fatty acids, or combinations thereof to a mammal.

Abstract translation: 本发明提供治疗或预防精神疾病，药物滥用障碍和其它病症（例如心血管疾病和癌症）的方法，包括给予治疗有效量的含胞嘧啶或含胞苷化合物，含肌酸的化合物，腺苷 含有腺苷升高化合物，ω-3脂肪酸或其组合。 本发明还提供了通过施用有效量的含细胞素或胞苷化合物，含肌酸的化合物，含腺苷，腺苷升高化合物，ω-3脂肪酸或其组合来增强神经发育和延迟早孕的方法 哺乳动物

公开(公告)号：WO00032211A1

公开(公告)日：2000-06-08

申请号：PCT/IB1999/001900

申请日：1999-11-29

IPC: A61K36/55 ,  A61K36/71 ,  A61P17/06 ,  A61K35/78

CPC classification number: A61K36/55 ,  A61K36/71 ,  A61K2300/00

Abstract: The invention discloses an enteral pharmaceutical preparation, which include black cumin oil (nigella sativa). The preparation may further includes dietary polyunsaturated fatty acids, such as flax oil (oleum lini).

Abstract translation: 本发明公开了一种肠内药物制剂，其包括黑孜然油（nigella sativa）。 制剂还可以包括膳食多不饱和脂肪酸，如亚麻油（发烟硫酸）。

公开(公告)号：WO9952359A9

公开(公告)日：2000-04-13

申请号：PCT/US9907008

申请日：1999-04-12

Applicant: WOODSTREAM CORP ,  ZOBITNE KAREN A ,  GEHRET MICHAEL J

Inventor： ZOBITNE KAREN A ,  GEHRET MICHAEL J

IPC: A01N65/44 ,  A01N65/08 ,  A01N65/22 ,  A01N65/24 ,  A01N65/28 ,  A01N65/36 ,  A01P7/00 ,  A61K36/534 ,  A61K36/537 ,  A61K36/54 ,  A61K36/55 ,  A61K36/61 ,  A61K36/752 ,  A61K36/87 ,  A61K36/8962 ,  A01N25/00 ,  A01N25/06 ,  A01N25/30 ,  A01N27/00 ,  A01N41/10 ,  A01N61/02 ,  A01N65/00

CPC classification number: A01N65/00 ,  A01N25/06 ,  A01N41/02 ,  A01N61/02 ,  Y02A50/338 ,  Y02A50/339 ,  Y02A50/34 ,  Y02A50/343 ,  Y02A50/347 ,  Y02A50/348 ,  Y02A50/351 ,  Y10S514/975 ,  A01N2300/00 ,  A01N65/06 ,  A01N65/08 ,  A01N65/20 ,  A01N65/22 ,  A01N65/24 ,  A01N65/28 ,  A01N65/36 ,  A01N65/42 ,  A01N65/44

Abstract: A synergistic insecticide is provided by the addition of sodium lauryl sulfate or lecithin to an essential oil, preferably an essential oil which has been deregulated by the Environmental Protection Agency, to enable independently inactive or relatively inactive materials to provide commercially acceptable insecticidal properties without the need for undesirable poisons that may be toxic to humans and pets.

Abstract translation: 通过将十二烷基硫酸钠或卵磷脂加入精油中，优选已被环境保护署解除调节的精油使得独立的无活性或相对无活性的材料能够在不需要的情况下提供商业上可接受的杀虫性质来提供协同杀虫剂 对于可能对人类和宠物有毒的不良毒药。

公开(公告)号：WO9732593A2

公开(公告)日：1997-09-12

申请号：PCT/GB9700622

申请日：1997-03-10

Applicant: ENERGISER PLC ,  MORTON MICHAEL STAFFORD ,  GRIFFITHS KEITH ,  ADLERCREUTZ CARL HERMAN THOMAS

Inventor： MORTON MICHAEL STAFFORD ,  GRIFFITHS KEITH ,  ADLERCREUTZ CARL HERMAN THOMAS

IPC: A21D2/36 ,  A21D13/08 ,  A61K36/185 ,  A61K36/48 ,  A61K36/55 ,  A61K36/736 ,  A61K36/899 ,  A61K35/78

CPC classification number: A61K36/736 ,  A21D2/36 ,  A21D13/80 ,  A61K36/185 ,  A61K36/48 ,  A61K36/55 ,  A61K36/752 ,  A61K36/899 ,  A61K2300/00

Abstract: There is provided a composition and method of treatment useful to combat disease states, such as cancer, especially before such disease states are clinically detectable or alternatively when they are less advanced. The composition is capable of elevating the levels of iso-flavonoids (e.g. genistein) and lignans (e.g. enterolactone) in the body to therapeutically useful levels. Conveniently the composition of the present invention is presented in the form of a foodstuff, conveniently in the form of a biscuit or "cookie" and contains a soya component, together with a flaxseed component and/or a rye component.

Abstract translation: 提供了用于对抗诸如癌症等疾病状态的治疗的组合物和方法，特别是在这些疾病状态在临床可检测之前或者当它们不太先进时。 组合物能够将体内异黄酮（例如染料木黄酮）和木脂素（例如肠内酯）的水平升高至治疗有用的水平。 方便地，本发明的组合物以食品的形式呈现，方便地以饼干或“饼干”的形式，并且含有大豆组分以及亚麻籽组分和/或黑麦组分。

公开(公告)号：WO2023041437A1

公开(公告)日：2023-03-23

申请号：PCT/EP2022/075126

申请日：2022-09-09

Applicant: BASF SE

Inventor： MACK, Sandra ,  GRAHAM, David ,  WEISSENEGGER, Markus ,  FALKOWSKI, Jürgen ,  ZIMNY, Antje

IPC: A61K36/55 ,  A61K8/00 ,  A61K9/00

Abstract: The present invention relates to a process for making an extract of Linum usitatissimum seeds. Furthermore, it relates to the extract itself and to a cosmetic composition comprising this extract. Furthermore, it relates to the use of this extract or of the cosmetic composition comprising this extract for hair styling or for conditioning or for protection against UV radiation.

公开(公告)号：WO2019115767A1

公开(公告)日：2019-06-20

申请号：PCT/EP2018/084955

申请日：2018-12-14

Applicant: VIRGINIA HEALTH FOOD LIMITED

Inventor： O'DOWD, Helen ,  SCHNEIDER, Christin ,  GONDA, Irene ,  GLEBOWSKA, Agnieszka

IPC: A23L7/10 ,  A61K36/9066 ,  A61K31/445 ,  A61K36/55 ,  A61K36/67 ,  A23L33/105 ,  A23L25/00 ,  A23L19/00

Abstract: A mixture of milled flaxseed, turmeric powder and piperine for prolonging the shelf life of milled flaxseed.

公开(公告)号：WO2018226192A9

公开(公告)日：2018-12-13

申请号：PCT/TR2018/050103

申请日：2018-03-16

Applicant: HELVACIZADE GIDA İLAÇ KİMYA SANAYİ VE TİCARET ANONİM ŞİRKETİ

Inventor： BÜYÜKHELVACIGİL, Mevlüt

IPC: A61K36/55 ,  A61K9/48 ,  A61K47/22

Abstract: In pharmaceutical industry; the invention relates to use of a herbal formulation containing linseed oil being rich in alpha-linolenic acid which is a herbal fatty acid containing Omega 3 on those who cannot use fish oil, particularly on vegetarians as a herbal omega 3 (ALA) source. Said herbal formulation comprises linseed oil, dl α-tocopherol, dl α-tocopheril acetate, glycerin, purified water and gelatin maintaining the integrity and formation of the content.